COVID-19 Vaccines and Vaccination
A section of Vaccines (ISSN 2076-393X).
Section Information
Aims
The aim of this “COVID-19 vaccines and vaccination” special issue is to provide with information on currently available and novel experimental approaches for the development of vaccines for the control of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and it associated coronavirus disease 2019 (COVID-19).
Scope
Global efforts to develop vaccines recently have resulted in 3 FDA-approved vaccines candidates with excellent safety and efficacy profiles in human clinical trials that have resulted in large-scale vaccination campaigns early in 2021.Currently, RNA-based vaccines and replication defective adenovirus-based vector have been used for the treatment of COVID-19 in humans. However, additional safe and effective vaccines are needed for the treatment of SARS-CoV-2 infection and its associated COVID-19 disease.
In this section “COVID-19 vaccines and vaccination” we will consider original research and review articles, including short reports and full-size manuscripts, covering aspects related to SARS-CoV-2 vaccine development for the treatment of COVID-19 disease. These include (but not limited to) antigen selection; subunit, inactivated, and live-attenuated vaccines; approaches to enhance innate and adaptive B- and T-cell protective responses; vaccine adjuvants; delivery methods and strategies; immunological responses to SARS-CoV-2 infection or COVID-19 disease; and animal models to assess protection efficacy against SARS-CoV-2 infection and COVID-19 disease.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- T-cell Immunity and Viral Pathogenicity on Vaccine Efficacy (Deadline: 6 October 2023)
- Vaccines for COVID-19 (Deadline: 7 October 2023)
- Immune Response of SARS-CoV-2 Infection and Anti-SARS-CoV-2 Vaccination (Deadline: 10 October 2023)
- SARS-CoV-2 Serological Studies around the World (Deadline: 20 October 2023)
- COVID-19 Vaccine Acceptance and Uptake: Insights from Behavioural and Social Sciences (Deadline: 31 October 2023)
- SARS-CoV-2 Vaccine Impact in Antibody Response (Deadline: 31 October 2023)
- Vaccination Intention against the COVID-19 Pandemic (Deadline: 31 October 2023)
- Immune Effectiveness of COVID-19 Vaccines (Deadline: 31 October 2023)
- Safety and Autoimmune Response to SARS-CoV-2 Vaccination (Deadline: 20 November 2023)
- Antibody Research in the Era of COVID-19 (Deadline: 30 November 2023)
- Research of Complications after Vaccination (Deadline: 30 November 2023)
- Trust in COVID-19 Vaccines, Policies, and Regulations (Deadline: 31 December 2023)
- The Effect of COVID-19 Vaccine Acceptance, Intention, and/or Hesitancy and Its Association with Our Health and/or Important Areas of Functioning (Deadline: 31 December 2023)
- SARS-CoV-2: Vaccines in the Pandemic Era (Deadline: 31 December 2023)
- Adverse Events of COVID-19 Vaccines (Deadline: 31 December 2023)
- Impact of COVID-19 and Non-COVID-19 Vaccination in Special Populations (Deadline: 31 December 2023)
- SARS-CoV-2 Infection in Women and Children (Deadline: 31 December 2023)
- Prevention of SARS-CoV-2 Infection and COVID-19: Safety, Immunogenicity and Effectiveness of Available Vaccines (Deadline: 31 December 2023)
- SARS-CoV-2 Infection and Vaccines for Patients with Renal Diseases (Deadline: 31 December 2023)
- Challenges to SARS-CoV-2 Vaccines: Infection, Variants, Reinfection (Deadline: 31 December 2023)
- Humoral and Cellular Response after COVID-19 Vaccination (Deadline: 31 December 2023)
- Neurological Complications Following COVID-19 Infection and COVID-19 Vaccination (Deadline: 31 December 2023)
- Ophthalmic Adverse Events following SARS-CoV-2 Vaccination (Deadline: 31 December 2023)
- COVID-19 Vaccination Coverage, Behaviors, and Interaction with Chronic Diseases (Deadline: 31 December 2023)
- Attitudes and Perspectives toward COVID-19 Vaccines (Deadline: 31 December 2023)
- Epidemiology, Vaccinology and Surveillance of COVID-19 (Deadline: 31 December 2023)
- Vaccine Equity as a Right to Health: How Can Advanced Technologies Address Global Inequalities in Vaccine Access, Efficacy, and Capacity Post-COVID? (Deadline: 31 December 2023)
- Vaccination Strategies for COVID-19 II (Deadline: 20 January 2024)
- Real Life Experience of the COVID-19 Vaccine: What Do You Need to Know? (Deadline: 31 January 2024)
- People’s Perception on COVID-19 Vaccine and Its Accessibility: Version II (Deadline: 1 February 2024)
- Management of COVID-19 through Vaccination: Past, Current and Future Strategies (Deadline: 28 February 2024)
- COVID-19 Vaccination, Role of Vaccines and Global Health (Deadline: 29 February 2024)
- Diagnosis for SARS-CoV-2 Infections (Deadline: 29 February 2024)
- Population Immunity and Persistence to SARS-CoV-2 Induced by Infection and Vaccination, Protection Against New Infections and Implication for Further Vaccination (Deadline: 29 February 2024)
- COVID-19 Vaccines and Immune Response (Deadline: 29 February 2024)
- New Trends in SARS-CoV-2 Variants and Vaccines (Deadline: 20 March 2024)
- State-of-the-Art Vaccine Research in AustralAsia (Deadline: 31 March 2024)
- COVID-19 and Vaccination Strategies in Global Health (Deadline: 31 March 2024)
- SARS-CoV-2 Variants: Unraveling Vaccines and Immune Responses (Deadline: 31 March 2024)
- Detection of SARS-CoV-2 Neutralizing Antibodies and Vaccine Development (Deadline: 30 April 2024)
- Knowledge, Attitudes and Associated Factors Surrounding COVID-19 Vaccination (Deadline: 31 May 2024)
- Knowledge, Attitudes, Beliefs and Hesitancy towards COVID-19 Vaccination and Booster Doses (Deadline: 31 May 2024)
Topical Collection
Following topical collection within this section is currently open for submissions:
